TGFB1 and renal fibrosis: These experimental results suggest that inhibition of tubular EMT to mitigate renal fibrosis via inhibiting the TGF-β1/Smad signaling pathway might be one of the mechanisms by which YSPDF was able to alleviate kidney damage.